Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Victoria

$44,000.00

Research Program in Structural Proteomics to Characterize Misfolded Proteins

FY 2017-18

Summary
Misfolded proteins and protein aggregates play a central role in the development of cancer and neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, Huntington's disease, Creutzfeld-Jakob disease, and ALS. This proposal is to develop a program to develop new methods for the study of protein folding and misfolding. This program would include the development of new chemical proteomics reagents and techniques designed to allow the determination of the 3-dimensional shapes of proteins and the determination of the interaction sites that are involved in protein-protein interactions and lead to aggregation. This field of research is called structural proteomics.Structural proteomics involves the use of special techniques and reagents, combined with a variety of different types of mass spectrometric instrumentation. I have already pioneered many structural proteomics approaches which have great potential for overcoming the challenges that have hindered the application of traditional structure biology methods to the study of proteins involved in neurological diseases. My proposal is for a program to expand my previously-developed set of reagents, techniques, and approaches -- which include crosslinking, surface modification, and hydrogen/deuterium exchange -- into a complete library of reagents and techniques that will enable the structural characterization of large proteins and protein complexes. These new structural proteomics techniques, developed as a part of this program, will then be applied to the 3D-structure determination of the study of the protein misfolding and aggregation processes to provide basic understanding of the development and progression of neurodegenerative diseases. Knowledge of the 3-dimensional structures of these proteins will enable the intelligent design of drugs that bind to these proteins, and act as inhibitors, thus preventing these diseases. These same basic science methods can be used to structurally characterize ""biosimilar"" protein drugs, a multi-billion dollar drug market.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
346194-2013
Name nom
Borchers, Christoph
Department département
Biochemistry and Microbiology
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2013
Award amount
44000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
5
Nb partie
5
Application title
Research Program in Structural Proteomics to Characterize Misfolded Proteins
Keyword
NSERC
Application summary
Misfolded proteins and protein aggregates play a central role in the development of cancer and neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, Huntington's disease, Creutzfeld-Jakob disease, and ALS. This proposal is to develop a program to develop new methods for the study of protein folding and misfolding. This program would include the development of new chemical proteomics reagents and techniques designed to allow the determination of the 3-dimensional shapes of proteins and the determination of the interaction sites that are involved in protein-protein interactions and lead to aggregation. This field of research is called structural proteomics.Structural proteomics involves the use of special techniques and reagents, combined with a variety of different types of mass spectrometric instrumentation. I have already pioneered many structural proteomics approaches which have great potential for overcoming the challenges that have hindered the application of traditional structure biology methods to the study of proteins involved in neurological diseases. My proposal is for a program to expand my previously-developed set of reagents, techniques, and approaches -- which include crosslinking, surface modification, and hydrogen/deuterium exchange -- into a complete library of reagents and techniques that will enable the structural characterization of large proteins and protein complexes. These new structural proteomics techniques, developed as a part of this program, will then be applied to the 3D-structure determination of the study of the protein misfolding and aggregation processes to provide basic understanding of the development and progression of neurodegenerative diseases. Knowledge of the 3-dimensional structures of these proteins will enable the intelligent design of drugs that bind to these proteins, and act as inhibitors, thus preventing these diseases. These same basic science methods can be used to structurally characterize ""biosimilar"" protein drugs, a multi-billion dollar drug market.
University of Victoria - $44,000 Grant (2017-18) | Canada Spends